Pathalys Pharma
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4242 Six Forks Rd Ste 820, Raleigh, Nort...Website
pathalys.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Pathalys Pharma
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of ESKD.Explore more
Pathalys Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pathalys Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Pathalys Pharma launches new products
Click to see if Pathalys Pharma had a recent Job posting/layoffs
Check if Pathalys Pharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Pathalys Pharma
Pathalys Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Pathalys Pharma has new funding data
Check out if Pathalys Pharma is spiking on competitors!
Earning: See what the market has to say on Pathalys Pharma recently announced quarterly report
Recommended Actions
Find VP level buyers at Pathalys Pharma
Find 2 more new buyers
Compare Similar Companies to Pathalys Pharma
Compare insights from companies similar to Pathalys Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pathalys Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pathalys Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pathalys Pharma.
Pathalys Pharma financials insights
Gather financial insights about Pathalys Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Debt
$150M
2024
Series B
$105M
Pathalys Pharma Tech Stack
A closer look at the technologies used by Pathalys Pharma
See more technologies
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Board of Directors
Executive Move
Board of Directors
Funding
Pathalys Pharma News & Media
Pathalys raises $105M to prepare kidney disease drug for FDA - Fierce Biotech
Pathalys Pharma has brought in $105 million via a series B fundraise that the kidney-disease-focused biotech will use to take its lead candidate through the final stages of clinical development.Pathalys Pharma Secures $105 Million Series B Financing
/PRNewswire/ -- Pathalys Pharma, Inc., a private biopharmaceutical company in the late stages of developing treatments for kidney disease, has successfully...Pathalys Pharma Appoints Dr. Bastian Dehmel as Chief Medical Officer
RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2024 /PRNewswire/ -- Pathalys Pharma, Inc., a private biopharmaceutical company in the late stages of developing treatments for kidney disease, today announced it has appointed Bastian Dehmel, M.D. as its Chief Medical Officer. In this role, Dr....Pathalys Pharma and Launch Therapeutics Announce First Patient Enrolled Ahead of Schedule in Pivotal Phase 3 Program for Upacicalcet in Patients Receiving Hemodialysis
Pathalys and LaunchTx leverage recently announced collaboration to accelerate enrollment for the upacicalcet development program. RESEARCH TRIANGLE PARK, N.C. and BOSTON, May 31, 2023 /PRNewswire/ -- Pathalys Pharma, Inc., a private, late-stage biopharma company co-founded by Catalys...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pathalys Pharma
Sign Up For FreeTo access detailed company insights
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of ESKD.... Read More
